The Role of Lipid-Lowering Therapy in Post-Stroke Patients: Update and Recommendations
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Lipid-Lowering Therapy in Post-Stroke Patients: Update and Recommendations
Authors
Keywords
-
Journal
Current Atherosclerosis Reports
Volume 25, Issue 11, Pages 889-898
Publisher
Springer Science and Business Media LLC
Online
2023-10-26
DOI
10.1007/s11883-023-01159-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients
- (2023) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Long-term Statin Use With the Risk of Intracerebral Hemorrhage: A Danish Nationwide Case-Control Study
- (2022) Daniel Albjerg Rudolph et al. NEUROLOGY
- 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association
- (2022) Steven M. Greenberg et al. STROKE
- European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack
- (2022) Jesse Dawson et al. European Stroke Journal
- Use of Lipid-Lowering Drugs After Intracerebral Hemorrhage
- (2022) Ashkan Shoamanesh et al. STROKE
- When Is a Placebo Not a Placebo
- (2022) Steven E. Nissen JAMA Cardiology
- Lipid-Lowering Therapy and Hemorrhagic Stroke Risk: Comparative Meta-Analysis of Statins and PCSK9 Inhibitors
- (2021) Borja E. Sanz-Cuesta et al. STROKE
- Deintensification or No Statin Treatment Is Associated With Higher Mortality in Patients With Ischemic Stroke or Transient Ischemic Attack
- (2021) Jennifer L. Dearborn-Tomazos et al. STROKE
- 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
- (2021) Dawn O. Kleindorfer et al. STROKE
- Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-IT
- (2021) Kazuma Oyama et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
- (2020) Salim S. Virani et al. CIRCULATION
- Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction: A Randomized Controlled Trial
- (2020) Are Annesønn Kalstad et al. CIRCULATION
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk
- (2020) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary
- (2019) Scott M. Grundy et al. CIRCULATION
- Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
- (2019) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2019) Catherine Owens Johnson et al. LANCET NEUROLOGY
- Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
- (2019) Irene Tramacere et al. BMC Medicine
- Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75)
- (2019) Yasuyoshi Ouchi et al. CIRCULATION
- Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease
- (2019) Anne C. Goldberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke
- (2019) Pierre Amarenco et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES
- (2019) J. Wouter Jukema et al. CIRCULATION
- Non-High-Density Lipoprotein Cholesterol and Risk of Stroke Subtypes and Coronary Heart Disease: The Japan Public Health Center-Based Prospective (JPHC) Study
- (2019) Isao Saito et al. Journal of Atherosclerosis and Thrombosis
- Increased Cardiovascular Risk in Hypertriglyceridemic Patients with Statin-Controlled LDL Cholesterol
- (2018) Gregory A Nichols et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use
- (2018) Michael G. Nanna et al. JAMA Cardiology
- Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks
- (2018) Theingi Aung et al. JAMA Cardiology
- High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real‐World Administrative Claims Analysis of Statin‐Treated Patients With High Residual Cardiovascular Risk
- (2018) Peter P. Toth et al. Journal of the American Heart Association
- Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- FISHing for the Miracle of Eicosapentaenoic Acid
- (2018) John J.P. Kastelein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease
- (2016) Robert Klempfner et al.
- Serum cholesterol levels, HMG-CoA reductase inhibitors and the risk of intracerebral haemorrhage. The Multicenter Study on Cerebral Haemorrhage in Italy (MUCH-Italy)
- (2016) Alessandro Pezzini et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease
- (2016) Robert Klempfner et al. Circulation-Cardiovascular Quality and Outcomes
- Statin use after intracerebral hemorrhage: a 10-year nationwide cohort study
- (2016) Shu-Yu Tai et al. Brain and Behavior
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cholesterol Levels and Risk of Hemorrhagic Stroke
- (2013) Xiang Wang et al. STROKE
- Total and High-Density Lipoprotein Cholesterol and Stroke Risk
- (2012) Yurong Zhang et al. STROKE
- Statin Therapy and the Risk of Intracerebral Hemorrhage
- (2012) James S. McKinney et al. STROKE
- Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
- (2010) Deepak L. Bhatt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started